Zur Rose Group AG
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. It also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany's best-known pharmacy brand, DocMorris With its business model, the Zur Rose Group offers high-quality, safe and cost-effective pharmaceutical care. It also excels in continuous development of digital healthcare services and as a platform technology provider. In addition, Zur Rose is actively driving forward its positioning as a comprehensive healthcare service provider, with focus on building up its European healthcare ecosystem networking qualified providers of products, services and digital solutions.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 11:18 |
Regulatory News Service
Obesity therapy support programme from DocMorris
|
English | 6.1 KB | |
| 2025-05-22 17:40 |
Share Issue/Capital Change
DocMorris AG announces number of shares sold in rights offering
|
English | 12.7 KB | |
| 2025-05-21 02:00 |
Share Issue/Capital Change
DocMorris AG announces number of shares sold in rights offering
|
English | 11.4 KB | |
| 2025-05-21 02:00 |
Share Issue/Capital Change
DocMorris AG gibt das Ergebnis ihres Bezugsrechtsangebots bekannt
|
German | 12.1 KB | |
| 2025-05-20 13:30 |
Major Shareholding Notification
Pelion invests in DocMorris
|
English | 11.8 KB | |
| 2025-05-14 09:00 |
Regulatory News Service
DocMorris: Aktuelle Kantar-Verbraucherbefragung zeigt weiter steigende Beliebth…
|
German | 4.8 KB | |
| 2025-05-09 20:28 |
Regulatory News Service
DocMorris AG shareholders approve capital increase and all proposals put forwar…
|
English | 15.6 KB | |
| 2025-05-08 06:58 |
General Meeting Notice
DocMorris announces final details on the agenda of today's Annual General Meeti…
|
English | 23.0 KB | |
| 2025-05-08 00:00 |
Regulatory News Service
Quarterly Report Q1 2025
|
English | 129.6 KB | |
| 2025-04-11 06:58 |
Regulatory News Service
DocMorris accelerates Rx growth to 52 per cent and secures CHF 200 million capi…
|
English | 24.0 KB | |
| 2025-04-10 06:00 |
Regulatory News Service
(Incl. information on banking syndicate:) DocMorris accelerates Rx growth to 52…
|
English | 773 bytes | |
| 2025-04-10 00:00 |
Regulatory News Service
Q1/2025 trading update and Outlook presentation
|
English | 2.3 MB | |
| 2025-03-14 06:58 |
Regulatory News Service
DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the…
|
English | 28.1 KB | |
| 2025-03-14 00:00 |
Corporate Governance Report
Corporate Governance
|
English | 223.0 KB | |
| 2025-03-14 00:00 |
Regulatory News Service
Annual Report 2024
|
English | 1.9 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Allmed Solutions Ltd. | Israel | ALMD | |
|
Biosynex | France | ALBIO | |
|
Bio-Works Technologies AB | Sweden | BIOWKS | |
|
Bonesupport Holding | Sweden | BONEX | |
|
Coloplast | Denmark | COLO | |
|
COLTENE Holding AG | Switzerland | CLTN | |
|
Convatec Group PLC | United Kingdom | CTEC | |
|
Cosma Spolka Akcyjna | Poland | COS | |
|
EssilorLuxottica | France | EL | |
|
Euromedis Groupe | France | ALEMG |